
ALS (Lou Gehrig's Disease)
Key takeaways
Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects the brain and spinal cord. It causes a worsening loss of voluntary muscle control, which affects movements like talking, swallowing, and walking.
There is currently no cure for ALS. However, treatments are available that can reduce symptoms and may help people with ALS to live longer.
ALS eventually results in loss of life. People typically live with ALS for 2 to 5 years. Some people will live longer.
There is currently no cure for ALS. However, treatments are available that can reduce symptoms and may help people with ALS to live longer.
The famous baseball player Lou Gehrig developed symptoms of the condition in the 1930s, and that's why it's also known as Lou Gehrig's disease.
What are the causes of ALS?
ALS can be classified as either sporadic or familial. Most cases are sporadic. That means no specific cause is known.
Familial ALS happens when the condition is inherited from a parent. Only about 5% to 10% of ALS cases are familial.
Other causes of ALS aren't well understood. Some factors that scientists think might contribute to ALS include:
free radical damage
imbalances in the chemical messenger glutamate
protein abnormalities, like misfolding
nerve inflammation
Military veterans are thought to be at higher risk for ALS, though the reasons for this are unclear. Some research suggests that smoking is a risk factor for ALS. Research on other possible environmental triggers is ongoing.
Demographic factors
Age: The likelihood of receiving an ALS diagnosis increases with age. The onset of symptoms in ALS usually occurs between the ages of 55 and 75, although symptoms can occur earlier.
Sex: According to statistics that group people into male and female categories, ALS is more common among males than females.
Race and ethnicity: Research suggests that white people are more likely to receive an ALS diagnosis than people of other racial or ethnic groups. According to the National Organization for Rare Diseases, more studies are needed to understand who's affected by ALS globally.
How often does ALS occur?
Every year, about 5,000 people in the United States receive an ALS diagnosis. Around 30,000 people in the U.S. are currently living with the condition. ALS affects people in all racial, social, and economic groups.
A 2016 study suggests that ALS is becoming more common. This may be because the population is aging.
What are the symptoms of ALS?
Both sporadic and familial ALS are associated with a progressive loss of motor neurons. As motor neurons become damaged, a person with ALS will start to have difficulty with voluntary movements in their limbs, mouth, or throat.
There are two main types of ALS. Each one is associated with a different set of symptoms at the time of diagnosis.
Limb onset
Around 70% of people with ALS have what's known as 'limb onset' ALS. This means that symptoms first appear in the arms or legs.
Symptoms in the arms (upper limb onset) include:
weakness in hands
stiff arms or hands
cramps in arms or hands
loss of dexterity, fumbling, or dropping objects
Symptoms in the legs (lower limb onset) include:
trouble with walking or running
tripping or stumbling
difficulty lifting the front half of the foot when walking, known as foot drop
Early symptoms are usually in either the arms or the legs, not both. Limb onset ALS usually progresses more slowly than other types.
Bulbar onset
'Bulbar onset' ALS is less common. In this type, ALS first affects a part of the brainstem known as the corticobulbar area. Symptoms include difficulty with speech and swallowing and muscle spasms in the face or throat.
There are also rare sub-types of ALS that are defined by other symptoms present at the time of diagnosis. These include respiratory onset ALS when difficulties with the breathing muscles are the earliest sign of illness.
Upper and lower motor neurons
You have two main types of motor neurons in your body: upper motor neurons and lower motor neurons. They work together to allow your brain to communicate with your muscles to make voluntary movements possible.
For example, when you decide to move your finger, your upper motor neurons first send signals from your brain to your spinal cord. Then, lower motor neurons carry signals from the spinal cord to the muscles that move your finger.
By definition, ALS affects both upper and lower motor neurons. But the condition may start by affecting one type more than the other, either the upper or the lower. Each type can result in different symptoms.
Symptoms of upper motor neuron disease include:
involuntary rhythmic muscle contractions, known as clonus
rigid muscles (spacticity)
overactive reflexes
Symptoms of lower motor neuron disease include:
limp (flaccid) muscles
muscle atrophy
spontaneous twitching
Weakness happens with both types of motor neuron disease.
Progression
The earliest symptoms of ALS may include small muscle twitches in your:
mouth
throat
face
limbs
But it's typical to notice muscle twitches from time to time. They're usually not a cause for concern. In early ALS, muscle twitches are likely to become more frequent over time.
Other early signs of ALS may include difficulty performing some everyday tasks. This could mean difficulty climbing stairs or getting up from a chair. It's also possible to have difficulty speaking or swallowing, or weakness in the arms, hands, or legs. You may also notice cramping.
Early symptoms tend to be asymmetrical, which means they only happen on one side.
As the condition progresses, the symptoms generally spread to both sides of the body. Muscle weakness, weight loss, and muscle atrophy are common. In the late stages of ALS, paralysis of the muscles occurs. Paralysis means the complete loss of voluntary movements.
ALS doesn't affect your senses, like seeing or hearing. Bowel and bladder control can be affected in later stages of the disease.
ALS is a terminal illness, which means that it eventually results in loss of life. People typically live with ALS for 2 to 5 years. Some people will live longer. Approximately 20% of people live with ALS for over 5 years, and 10% for more than 10 years. The most common life-ending event in ALS is respiratory failure.
What body systems are affected by ALS?
While ALS specifically affects the motor neurons of the brain and spinal cord, other body systems that rely on these neurons will be impacted as the disease progresses. As the ability to control voluntary muscles declines, functions like breathing, speaking, and moving are affected.
ALS progresses differently for everyone. A doctor or neurologist who specializes in the condition can help those with ALS understand what to expect.
ALS complications
ALS can affect many aspects of daily functioning. These include:
Respiratory system and breathing
ALS causes the muscles controlling breathing to weaken over time. Breathing is likely to become more laborious. As the respiratory system weakens, the risk of pneumonia increases. Eventually, as the condition progresses, a ventilator may be required to assist breathing.
Speaking
Muscles in the mouth, jaw, and throat tend to lose strength and mobility. Because of this, it can become hard for a person with ALS to make themselves understood when speaking. In severe cases, some people lose the ability to produce speech.
Eating
ALS usually affects chewing and swallowing, making eating more difficult. Choking is a possible complication.
Weight loss and malnutrition
Because eating can become challenging and ALS may cause people to burn calories more quickly, it's common to experience rapid weight loss and undernutrition.
Moving
Standing and walking will generally become more difficult over time. Some people will have trouble moving their arms.
The changes will happen differently for each person. But in general, more muscles will be affected, and the loss of function will become more severe as ALS progresses. Pressure sores are a possible complication as moving becomes harder.
Cognition
ALS causes cognitive changes in up to 50% of cases. These changes can affect language and executive function. Dementia is possible but less common. In ALS, physical changes to the brain can also cause uncontrollable laughing and crying, known as emotional lability.
Some variants of ALS are more commonly associated with cognitive changes, like ALS-frontotemporal spectrum disorder.
Mood
It's typical to feel a range of emotions when coping with a serious illness. Managing symptoms and life changes caused by ALS can be emotionally difficult. For some people with ALS, these changes can result in anxiety and depression.
If you're living with ALS and notice changes in your daily functioning, talk with your doctor and healthcare team. Medication and support can help maintain quality of life, even as symptoms progress.
Does ALS affect thinking?
Cognitive changes are common among people with ALS, affecting between 30% and 50% of those with the disease. The changes are usually classified as mild to moderate. Difficulty with reasoning, planning, and slowed thinking are among the most common cognitive symptoms of ALS.
Behavioral changes like emotional lability (uncontrollable laughing and crying) are also possible, even if cognition is otherwise unaffected.
It's less common, but ALS-related dementia can also occur if there's cell degeneration in the frontotemporal regions of the brain.
How is ALS diagnosed?
ALS is usually diagnosed by a neurologist. There's no specific test for ALS. The process of establishing a diagnosis can take anywhere from weeks to months.
An ALS diagnosis may be considered if someone has nerve and muscle health concerns that get worse over time. A doctor will watch for increasing symptoms like:
muscle weakness
muscle atrophy
twitching
cramps
rigid tissue, known as contracture
These symptoms can also be caused by a number of other conditions. Therefore, a diagnosis requires your doctor to rule out other health concerns. This is done with a series of diagnostic tests, including:
an EMG test to evaluate the electrical activity of your muscles
nerve conduction studies to test your nerve function
an MRI scan that shows which parts of your nervous system are affected
blood tests to evaluate your general health and nutrition
Genetic tests may also be useful for people with a family history of ALS.
How is ALS treated?
Many different areas of functioning can be affected as control over voluntary movements declines. Treatments and supports are available to address most symptoms.
A team of doctors and specialists often work together to treat people with ALS. Specialists involved in the ALS team might include:
a neurologist who is skilled in the management of ALS
a doctor who specializes in physical medicine and rehabilitation (physiatrist)
a dietitian
a gastroenterologist
an occupational therapist
a respiratory therapist
a speech therapist
a social worker
a psychologist
a pastoral care professional
a doctor who specializes in palliative care
Family members should talk with people with ALS about their care. As the condition progresses, some people may need support when making medical decisions.
Connecting with a local ALS society can help people with ALS and their families access resources and support.
Assistive devices
Assistive devices like braces, mattresses, and wheelchairs can reduce pain by supporting the body in a more comfortable position.
Some people may need nutritional support, like a feeding tube (enteral feeding).
As speech becomes more difficult, communication tools provide another way to express thoughts and needs. Options include communication boards and electronic assistive communication devices.
If you're considering assistive devices, it's best to consult with your healthcare team to find the right options for you.
Medications
Two medications — riluzole (Rilutek, Tiglutik, Exservan) and edaravone (Radicava) — are approved for the treatment of ALS.
Riluzole appears to reduce a particular kind of nerve damage called glutamate-induced excitotoxicity. It can slow the progression of respiratory symptoms and prolong life by several months.
Edaravone (Radicava) appears to help with ALS symptoms by reducing oxidative stress. It can slow the progression of ALS, especially for those in the early stages of the condition.
Other medications may be used to treat the symptoms of ALS. Some of these medications include:
mexiletine and baclofen, for muscle cramps and spasms
nonsteroidal anti-inflammatory drugs (NSAIDs) and morphine, for pain management
dextromethorphan/quinidine (Nuedexta), for emotional lability
As of 2020, more than 40 potential new medications for ALS are being studied. Clinical trials for stem cell therapy are also underway. But stem cell therapy hasn't yet been proven to be an effective treatment for ALS.
Nonmedical treatments
Your doctor may recommend therapies like heat treatments, exercise, and physical therapy to reduce ALS symptoms. These should only be undertaken as directed by your healthcare team.
Massage, meditation, and other complementary and alternative therapies may also help with relaxation and comfort. Before starting any nonmedical treatment, it's important to discuss it with your doctor.
What is the long-term outlook for people with ALS?
There's currently no cure for ALS. But medication and supportive care can improve quality of life. Make it a priority to discuss new or changing symptoms with your healthcare team. Proper treatment and support can help those with ALS live happily and comfortably for as long as possible.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


WebMD
23 minutes ago
- WebMD
FDA Approves First Twice-Yearly Shot to Prevent HIV
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012, the drug – known as lenacapavir but sold under the name Yeztugo – offers a new way to protect against this life-threatening infection that affects more than a million people in the U.S. and has no cure. The shot is given before potential exposure to the virus. HIV spreads through unprotected sex and shared needles (including dirty needles from tattoos and body piercings). It weakens the immune system, and in its advanced stage, the body can no longer fight off infections, leading to acquired immune deficiency syndrome (AIDS). Only about a third of eligible people in the U.S. use available HIV prevention, with especially low use among women, Black/African American and Hispanic communities, and people in the South. This is mainly due to stigma, low awareness about existing options, and challenges with daily pills or frequent shots. Carlos del Rio, MD, a distinguished professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine, said that getting a shot just twice a year could make it easier for people to stick with prevention. "Yeztugo could be the transformative PrEP [pre-exposure prophylaxis] option we've been waiting for – offering the potential to boost PrEP uptake and persistence and adding a powerful new tool in our mission to end the HIV epidemic," said del Rio, who is also co-director of the Emory Center for AIDS Research in Atlanta. Gilead, the drug's maker, said the FDA approved Yeztugo based on two major studies, which showed that it worked better than taking a daily pill form of PrEP in preventing HIV with a nearly 100% success rate. In one trial, none of the 2,134 women who received Yeztugo got HIV, while in the other, only two out of 2,179 people did. It was well tolerated with no new safety concerns, which led the academic journal Science to name lenacapavir as its 2024 "Breakthrough of the Year." Yeztugo attacks a protective shell that HIV needs to stay alive, which helps stop the virus from growing and spreading. Most HIV drugs only work at one part of the virus's life cycle, but Yeztugo works at several points. It also still works even if other HIV drugs have stopped working. It is given as a shot under the skin and is only for people who test negative for HIV. Before starting Yeztugo and before each shot, your provider will test for HIV to prevent the virus from developing resistance to the medication. The treatment begins with two shots and two tablets, followed by two more tablets the next day – then continues with one shot every six months. If a shot is delayed by over two weeks, a weekly pill can be used for up to six months. If over 28 weeks pass with no treatment, patients may need to restart. If a patient gets HIV while on Yeztugo, they'll need full HIV treatment, as Yeztugo alone isn't enough. Yeztugo helps lower the risk of HIV when taken as prescribed, along with safe sex practices like using condoms.
Yahoo
26 minutes ago
- Yahoo
Cardinal Health, Inc. (CAH) CEO Is 'Terrific,' Says Jim Cramer
Cardinal Health, Inc. (NYSE:CAH) is one of the . Cardinal Health, Inc. (NYSE:CAH) is one of the biggest healthcare products and services providers in America. The shares are up by 36% year-to-date as they have benefited from strong earnings and other tailwinds. Cramer has discussed Cardinal Health, Inc. (NYSE:CAH) several times in 2025. He believes that the firm's specialty pharma business is a key differentiating factor and added that it could benefit if the Trump Administration decides to shake things up in the pharmaceutical supply chain. Here are his latest thoughts about Cardinal Health, Inc. (NYSE:CAH): 'Okay, you know I got a company, I mentioned it yesterday, Cardinal Health. These, it's not a middleman. Everyone thinks it's just a middleman. Jason Hollar's carving out a real place to make healthcare, let's say better, streamlined, and cheaper. I just think this guy's terrific, and I'm happy to have him on the show. He's not a villain.' Cramer discussed Cardinal Health, Inc. (NYSE:CAH) in detail in May. Here is what he said: 'These stocks. . .are seemingly perpetual residents on the new high list. Over the long haul, they're some of the best performers out there, and they've done great this year, as is pretty much always the case. And yet, doesn't it always feel like the drug distributors are just one bad day away from falling apart… Let's not forget that the drug distributors are making fortunes right now. Cardinal Health turned in an excellent set of numbers two weeks ago with double-digit earnings growth. Management put through a big boost in their full-year earnings forecast. Cardinal stock jumped 3% in response, climbing from $141 to $145, and it kept running for really a week after that, eventually setting at an all-time high of $154 just last Thursday. What a fabulous move… A senior physician in a modern healthcare institution administering medication to a patient. Now, if you really want to own one, and I do like this one, Cardinal Health is the one to do it with because it provides a lot more value-added services than the others. Now, we've had Cardinal on several times, and I think they're doing some very innovative things. They are impressive, they're beyond middlemen.' While we acknowledge the potential of CAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Forbes
29 minutes ago
- Forbes
How Women-Led Companies Are Changing The Healthcare Game
If you've ever had to jump through hoops to get an appointment (albeit one three months away, even though you're struggling with symptoms now), felt dismissed in the exam room or paid out of pocket for essential care that wasn't covered by insurance, you're not alone. For many women, getting quality healthcare that's accessible, affordable and respectful of their time and privacy can feel like a full-time job. From fragmented systems to outdated research that still centers on male biology, the barriers to truly effective women's healthcare run deep. That's why a wave of innovative companies—many of them women-led—are stepping in to fill the gap. Read more to learn about telehealth platforms that deliver stigma-free reproductive care, at-home testing that empowers women with data and virtual nutrition counseling that actually takes insurance to help challenge the status quo and give women more agency in their healthcare decisions. For many women, it's challenging to get affordable quality healthcare from a provider who truly ... More listens. Common barriers to care There are a number of factors in what keeps women from seeking care. Affordability, accessibility, and privacy concerns are just a few of the factors that come up. Monica Cepak, CEO of Wisp — the largest women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions, says, 'Some of women's main concerns are around getting access to affordable care. Patients also are concerned around their privacy, especially with things like STI testing and abortion care. You also see a lot of fragmentation in the marketplace.' It's easy to get overwhelmed when you have to go to different providers for all different health concerns. Vanessa Risetto, MS, RD, co-founder of nutrition platform Culina Health, notes that lack of insurance coverage keeps many women seeking support from a registered dietitian when making lifestyle changes. 'Historically, it's been all cash pay,' she says, for quality nutrition care, 'so for a regular person, it felt like you could never access that and it puts you in the mindset of, 'if I have to do this, I have to spend this kind of money,' and it also drove the mindset that if someone takes insurance, they must not be good.' She adds that because the registered dietitian license isn't protected, it can lead people to seek nutrition advice from uncredentialed influencers, which often can be unproductive or at its worst, dangerous. Priyanka Jain is the co-founder of Evvy—a female-founded women's health platform that offers precision vaginal healthcare via at-home testing and virtual coaching. She founded Evvy with the mission of closing the gender health data gap by discovering and leveraging overlooked female biomarkers, starting with the vaginal microbiome. 'As a founder but also as a woman who has been a patient of the healthcare system, I always joke that I had to start Evvy. I think you can feel the many ways that our healthcare system has not prioritized us.' She points to the fact that women weren't included in clinical research in the United States until 1993. 'Unfortunately, we're met with a healthcare system that doesn't really understand what health and disease looks like when the person that we're talking about has a female body. If you think about it historically, we essentially studied middle-aged white men. We made the ranges smaller for whatever was predictive of health and disease in those people. And then we assumed we had healthcare for women,' she adds. 'However, the female body has so many unique biomarkers, ways it's trying to tell us where things are going well and where we need help, but we're just not measuring or tracking any of those signals because we don't realize that they're predictive of health and disease because we never studied women.' Telehealth platforms offer many options for accessible healthcare for women. Improving access The digital health space has seen a lot of growth in recent years as companies seek to close healthcare gaps by offering accessible, affordable options. In the case of Wisp, Cepak says, 'We want to help lead innovation in this space so women have more options. We want to balance treatment with preventive care. Our goal is to be that single sign-on experience for women as they navigate major milestones of their health journey and plug into their lives to make accessing affordable, fast care that much easier. The name 'wisp' comes from the idea that women shouldn't have to whisper about their needs.' They're focused on optimizing accessibility to care and making it possible to get care through one provider 'as opposed to jumping around to so many different ones.' It's exhausting to try and remember all that login info, she says, and when those many practitioners aren't in touch with each other, it can contribute to getting mixed advice and feeling overwhelmed. Jain shares that there are currently about 1000 providers across the US 'who work through Evvy who refer their patients to the test,' but that a huge piece of the business is coming from patients seeking out the test independently. 'They can come to the website and order a vaginal health test and then one of their providers signs the order for them.' This is especially helpful for women living in rural areas where access to providers who specialize in women's vaginal health is lacking. Additionally, because insurance reimbursement for so many women's health issues is often minimal at best, paying a flat fee that involves both testing and consultation is a more cost-effective option. Because Evvy has such a large dataset, she adds, it offers the opportunity to research the vaginal microbiome and its impact on many aspects of women's health beyond just vaginitis, which is at present the primary issue women come to the platform for. Risetto shares that Culina, which she founded with her colleague Tamar Samuels in 2020, was 'first to market taking insurance, hiring smart RDs and showing that our profession is worthwhile.' They've built an award-winning virtual platform featuring registered dietitians with a variety of specialities who are in-network with many insurance companies, making nutrition care affordable for people who previously would not have been able to afford it. While they work with men and women, they offer services catered to women, such as nutrition to support hormone health, fertility, as pregnancy and postpartum health. Educating yourself on your own body and being ready to share that data with a provider can ... More facilitate shared decision making. Tips for Advocating for Yourself If you are dealing with a health issue and not getting support from your doctor, says Jain, don't be afraid to keep pushing. 'If you feel like something is wrong, you are probably right, even if you don't have the exact tools to validate that. So I really feel like we can be so much further as an industry if we just listen to women. And then my hope is that we put more data behind the lived experiences that so many women have.' She hopes that providing care and actually starting to study the things that women have done for generations will eventually provide the data to show what works and what doesn't work. 'Try to get as much data on your body as you can, and seek out the services that will help you access novel types of testing and comprehensive types of testing. Having that data helps you point to where issues are, which can then point to potential solutions.' If you struggle with feeling like your provider is too busy to listen to you, she adds, show up to appointments with that data. 'It makes it easier for providers when we do as much education as we can before we go to the appointment.' You use a service like Evvy, she explains, to get insight on what might be going on so that when you do get that precious facetime with your doctor, 'you're not saying, 'what is this and what does it mean?' Instead, you're saying, 'okay, these are my three options. Can we talk about which one is the best for me based on my personal medical history?'And then you can participate in what we always talk about as shared decision making.' The more you can do to be educated upfront about your own health can help you get the care you need, she adds. 'But also, don't be resigned to having a provider that won't listen to you.' Cepak encourages spreading the word about healthcare resources that you have found helpful. She says, 'Getting quality care shouldn't have to be that hard. I think that, ultimately, it comes down to education, awareness, and word of mouth. We have made a lot of progress in de-stigmatizing this space. Women trust other women. If you've had a positive experience getting quality care from an online provider, share that with friends and family.' And if your experience leaves you fired up to create your own resource to help close the care gap, Risotto has some sage advice: 'Run it lean. Don't get distracted by all the flashiness. That stuff is not sustainable. Run your own race. Just go with that. If you're trying to raise capital, VCs get a thousand deals and only say yes to a few. Every time you pitch, it's practice. Take the feedback and use it and remember that you only need one train to get it out of the station. Show them why they should say yes to you.'